Fc Receptor-Mediated Phagocytosis in Tissues as a Potent Mechanism for Preventive and Therapeutic HIV Vaccine Strategies

While the development of a protective HIV vaccine is the ultimate goal of HIV research, to date only one HIV vaccine trial, the RV144, has successfully induced a protective response. The 31% protection from infection achieved in the RV144 trial was linked to the induction of non-neutralizing antibod...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mucosal Immunol
Autori principali: Sips, Magdalena, Krykbaeva, Marina, Diefenbach, Thomas J., Ghebremichael, Musie, Bowman, Brittany A., Dugast, Anne-Sophie, Boesch, Austin W., Streeck, Hendrik, Kwon, Douglas S., Ackerman, Margaret E., Suscovich, Todd J., Brouckaert, Peter, Schacker, Timothy W., Alter, Galit
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4988947/
https://ncbi.nlm.nih.gov/pubmed/26883728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mi.2016.12
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi